CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma

Cerebrospinal fluid and urinary biomarkers in multiple sclerosis

(2013) R. Dobson et al.   ACTA NEUROLOGICA SCANDINAVICA

CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma

(2013) J. L. Rubenstein et al.   BLOOD

Primary brain tumours in adults

(2012) Damien Ricard et al.   LANCET

Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system

(2011) A. Baraniskin et al.   BLOOD

Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system

(2011) Alexander Baraniskin et al.   BRITISH JOURNAL OF HAEMATOLOGY

Cellular immune activation markers neopterin and beta 2-microglobulin are not elevated in the cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

(2011) Katharina Stoeck et al.   JOURNAL OF NEUROIMMUNOLOGY

Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL)

(2011) Takashi Sasayama et al.   NEURO-ONCOLOGY

Different lymphoid cell populations produce varied levels of neopterin, β2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha

(2010) B. HOFMANN et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Detection of free immunoglobulin light chains in cerebrospinal fluids of patients with central nervous system lymphomas

(2010) Roland Schroers et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Neopterin, a prognostic marker in human malignancies

(2009) Robert Sucher et al.   CANCER LETTERS

Protein Biomarker Identification in the CSF of Patients With CNS Lymphoma

(2007) Sushmita Roy et al.   JOURNAL OF CLINICAL ONCOLOGY